3-N-Butylphthalide
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Butylphthalide.
Abciximab
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Abciximab.
Abiraterone
The serum concentration of Ibrutinib can be increased when it is combined with Abiraterone.
Advertisement
Acenocoumarol
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Acenocoumarol.
Acetaminophen
The serum concentration of Ibrutinib can be increased when it is combined with Acetaminophen.
Acetazolamide
The serum concentration of Ibrutinib can be increased when it is combined with Acetazolamide.
Advertisement
Acetyl salicylate
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Acetylsalicylic acid.
Acetyl Sulfisoxazole
The serum concentration of Ibrutinib can be increased when it is combined with Acetyl sulfisoxazole.
Acetyldigitoxin
Acetyldigitoxin may decrease the cardiotoxic activities of Ibrutinib.
Advertisement
Albuterol
The serum concentration of Ibrutinib can be increased when it is combined with Salbutamol.
Aldesleukin
The serum concentration of Ibrutinib can be increased when it is combined with Aldesleukin.
alpha Tocopherol
Vitamin E may increase the antiplatelet activities of Ibrutinib.
Alprazolam
The serum concentration of Ibrutinib can be increased when it is combined with Alprazolam.
Alprostadil
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Alprostadil.
Ambroxol
The serum concentration of Ibrutinib can be increased when it is combined with Ambroxol.
Amiodarone
The serum concentration of Ibrutinib can be increased when it is combined with Amiodarone.
Amlodipine
The serum concentration of Ibrutinib can be increased when it is combined with Amlodipine.
Amprenavir
The serum concentration of Ibrutinib can be increased when it is combined with Amprenavir.
Anagrelide
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Anagrelide.
Anastrozole
The serum concentration of Ibrutinib can be increased when it is combined with Anastrozole.
Ancestim
The risk or severity of cytotoxicity can be increased when Ancestim is combined with Ibrutinib.
Ancrod
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Ancrod.
Anhydrous Tacrolimus
The serum concentration of Ibrutinib can be increased when it is combined with Tacrolimus.
Anthrax immune globulin, human
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Anthrax immune globulin human.
Antipyrine
The serum concentration of Ibrutinib can be increased when it is combined with Antipyrine.
Antithrombin III
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Antithrombin III human.
Antithrombin III, Human
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Antithrombin III human.
Apalutamide
The serum concentration of Ibrutinib can be decreased when it is combined with Apalutamide.
Apixaban
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Apixaban.
Aprepitant
The serum concentration of Ibrutinib can be increased when it is combined with Aprepitant.
Ardeparin
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Ardeparin.
Argatroban
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Argatroban.
Argatroban Anhydrous
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Argatroban.
Arsenic Trioxide
The serum concentration of Ibrutinib can be increased when it is combined with Arsenic trioxide.
Artemether
The metabolism of Ibrutinib can be decreased when combined with Artemether.
Aspirin
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Acetylsalicylic acid.
Astemizole
The serum concentration of Ibrutinib can be increased when it is combined with Astemizole.
Atazanavir
The serum concentration of Ibrutinib can be increased when it is combined with Atazanavir.
Atomoxetine
The serum concentration of Ibrutinib can be increased when it is combined with Atomoxetine.
Atorvastatin
The serum concentration of Ibrutinib can be increased when it is combined with Atorvastatin.
Azelastine
The serum concentration of Ibrutinib can be increased when it is combined with Azelastine.
Azithromycin
The serum concentration of Ibrutinib can be increased when it is combined with Azithromycin.
BCG Vaccine
The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Ibrutinib.
BCG, Live, Connaught Strain
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Bacillus calmette-guerin substrain connaught live antigen.
BCG, Live, Tice Strain
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Bacillus calmette-guerin substrain tice live antigen.
Becaplermin
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Becaplermin.
Betamethasone
The serum concentration of Ibrutinib can be increased when it is combined with Betamethasone.
Betaxolol
The metabolism of Ibrutinib can be decreased when combined with Betaxolol.
Bevacizumab
Bevacizumab may increase the cardiotoxic activities of Ibrutinib.
Bevacizumab-Awwb
Bevacizumab may increase the cardiotoxic activities of Ibrutinib.
Bicalutamide
The serum concentration of Ibrutinib can be increased when it is combined with Bicalutamide.
Bifonazole
The serum concentration of Ibrutinib can be increased when it is combined with Bifonazole.
Bivalirudin
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Bivalirudin.
Black Cohosh Extract
The serum concentration of Ibrutinib can be increased when it is combined with Cimicifuga racemosa.
Boceprevir
The serum concentration of Ibrutinib can be increased when it is combined with Boceprevir.
Bortezomib
The serum concentration of Ibrutinib can be increased when it is combined with Bortezomib.
Bosentan
The serum concentration of Ibrutinib can be decreased when it is combined with Bosentan.
Bosentan Anhydrous
The serum concentration of Ibrutinib can be decreased when it is combined with Bosentan.
Brentuximab Vedotin
The serum concentration of Ibrutinib can be increased when it is combined with Brentuximab vedotin.
Brigatinib
The serum concentration of Ibrutinib can be decreased when it is combined with Brigatinib.
Bromocriptine
The serum concentration of Ibrutinib can be increased when it is combined with Bromocriptine.
Buprenorphine
The serum concentration of Ibrutinib can be increased when it is combined with Buprenorphine.
Bupropion
The metabolism of Ibrutinib can be decreased when combined with Bupropion.
Cabazitaxel
The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Ibrutinib.
Cabergoline
The serum concentration of Ibrutinib can be increased when it is combined with Cabergoline.
Caffeine
The serum concentration of Ibrutinib can be increased when it is combined with Caffeine.
Cangrelor
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Cangrelor.
Capsaicin
The serum concentration of Ibrutinib can be increased when it is combined with Capsaicin.
Carbamazepine
The serum concentration of Ibrutinib can be decreased when it is combined with Carbamazepine.
Caspofungin
The serum concentration of Ibrutinib can be increased when it is combined with Caspofungin.
Celecoxib
The metabolism of Ibrutinib can be decreased when combined with Celecoxib.
Ceritinib
The serum concentration of Ibrutinib can be increased when it is combined with Ceritinib.
Cerivastatin
The serum concentration of Ibrutinib can be increased when it is combined with Cerivastatin.
Certoparin
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Certoparin.
Chloramphenicol
The serum concentration of Ibrutinib can be increased when it is combined with Chloramphenicol.
Chloroquine
The metabolism of Ibrutinib can be decreased when combined with Chloroquine.
Chlorpromazine
The metabolism of Ibrutinib can be decreased when combined with Chlorpromazine.
Chlorzoxazone
The serum concentration of Ibrutinib can be increased when it is combined with Chlorzoxazone.
Cholecalciferol
The metabolism of Ibrutinib can be decreased when combined with Cholecalciferol.
Cilostazol
The serum concentration of Ibrutinib can be increased when it is combined with Cilostazol.
Cimetidine
The serum concentration of Ibrutinib can be increased when it is combined with Cimetidine.
Cinacalcet
The metabolism of Ibrutinib can be decreased when combined with Cinacalcet.
Ciprofloxacin
The serum concentration of Ibrutinib can be increased when it is combined with Ciprofloxacin.
Cisapride
The serum concentration of Ibrutinib can be increased when it is combined with Cisapride.
Citalopram
The metabolism of Ibrutinib can be decreased when combined with Citalopram.
Citric Acid
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Citric Acid.
Citric Acid, Anhydrous
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Citric Acid.
Clarithromycin
The serum concentration of Ibrutinib can be increased when it is combined with Clarithromycin.
Clemastine
The serum concentration of Ibrutinib can be increased when it is combined with Clemastine.
Clindamycin
The serum concentration of Ibrutinib can be increased when it is combined with Clindamycin.
Clobazam
The metabolism of Ibrutinib can be decreased when combined with Clobazam.
Clofazimine
The serum concentration of Ibrutinib can be increased when it is combined with Clofazimine.
Clofezone
The serum concentration of Ibrutinib can be increased when it is combined with Rabeprazole.
Clomiphene
The serum concentration of Ibrutinib can be increased when it is combined with Clomifene.
Clomipramine
The metabolism of Ibrutinib can be decreased when combined with Clomipramine.
Clopidogrel
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Clopidogrel.
Clotiazepam
The serum concentration of Ibrutinib can be increased when it is combined with Clotiazepam.
Clotrimazole
The serum concentration of Ibrutinib can be increased when it is combined with Clotrimazole.
Clozapine
The serum concentration of Ibrutinib can be increased when it is combined with Clozapine.
Cobicistat
The serum concentration of Ibrutinib can be increased when it is combined with Cobicistat.
Cocaine
The serum concentration of Ibrutinib can be increased when it is combined with Cocaine.
Colchicine
The serum concentration of Ibrutinib can be increased when it is combined with Colchicine.
Conivaptan
The serum concentration of Ibrutinib can be increased when it is combined with Conivaptan.
Cortisone Acetate
The serum concentration of Ibrutinib can be increased when it is combined with Cortisone acetate.
Crizotinib
The serum concentration of Ibrutinib can be increased when it is combined with Crizotinib.
Curcumin
The serum concentration of Ibrutinib can be increased when it is combined with Curcumin.
Cyclophosphamide
The serum concentration of Ibrutinib can be increased when it is combined with Cyclophosphamide.
Cyclophosphamide Anhydrous
The serum concentration of Ibrutinib can be increased when it is combined with Cyclophosphamide.
Cyclosporine
The serum concentration of Ibrutinib can be increased when it is combined with Cyclosporine.
Dabigatran Etexilate
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Dabigatran etexilate.
Dabrafenib
The serum concentration of Ibrutinib can be decreased when it is combined with Dabrafenib.
Dalfopristin
The serum concentration of Ibrutinib can be increased when it is combined with Dalfopristin.
Dalteparin
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Dalteparin.
Danaparoid
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Danaparoid.
Danazol
The serum concentration of Ibrutinib can be increased when it is combined with Danazol.
Darifenacin
The metabolism of Ibrutinib can be decreased when combined with Darifenacin.
Darunavir
The serum concentration of Ibrutinib can be increased when it is combined with Darunavir.
Dasatinib
The serum concentration of Ibrutinib can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Ibrutinib can be increased when it is combined with Dasatinib.
Daunorubicin
The serum concentration of Ibrutinib can be increased when it is combined with Daunorubicin.
Deferasirox
The serum concentration of Ibrutinib can be decreased when it is combined with Deferasirox.
Defibrotide
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Defibrotide.
Delavirdine
The serum concentration of Ibrutinib can be increased when it is combined with Delavirdine.
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Ibrutinib.
Desipramine
The serum concentration of Ibrutinib can be increased when it is combined with Desipramine.
Desirudin
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Desirudin.
Deslanoside
Deslanoside may decrease the cardiotoxic activities of Ibrutinib.
Dexamethasone
The serum concentration of Ibrutinib can be increased when it is combined with Dexamethasone.
Dextran
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Dextran.
Diacetylrhein
The serum concentration of Ibrutinib can be increased when it is combined with Diacerein.
Diazepam
The serum concentration of Ibrutinib can be increased when it is combined with Diazepam.
Dicumarol
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Dicoumarol.
Diethylstilbestrol
The serum concentration of Ibrutinib can be increased when it is combined with Diethylstilbestrol.
Digitoxin
Digitoxin may decrease the cardiotoxic activities of Ibrutinib.
Digoxin
Digoxin may decrease the cardiotoxic activities of Ibrutinib.
Dihydroergotamine
The serum concentration of Ibrutinib can be increased when it is combined with Dihydroergotamine.
Diltiazem
The serum concentration of Ibrutinib can be increased when it is combined with Diltiazem.
Dimethyl Sulfoxide
The serum concentration of Ibrutinib can be increased when it is combined with Dimethyl sulfoxide.
Diphenhydramine
The metabolism of Ibrutinib can be decreased when combined with Diphenhydramine.
Dipyridamole
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Dipyridamole.
Dipyrone
The risk or severity of myelosuppression can be increased when Metamizole is combined with Ibrutinib.
Docetaxel
The serum concentration of Ibrutinib can be increased when it is combined with Docetaxel.
DOCETAXEL ANHYDROUS
The serum concentration of Ibrutinib can be increased when it is combined with Docetaxel.
Dothiepin
The metabolism of Ibrutinib can be decreased when combined with Dosulepin.
Doxorubicin
The serum concentration of Ibrutinib can be increased when it is combined with Doxorubicin.
Doxorubicin Hydrochloride
The serum concentration of Ibrutinib can be increased when it is combined with Doxorubicin.
Doxycycline
The serum concentration of Ibrutinib can be increased when it is combined with Doxycycline.
Doxycycline Anhydrous
The serum concentration of Ibrutinib can be increased when it is combined with Doxycycline.
Dronedarone
The serum concentration of Ibrutinib can be increased when it is combined with Dronedarone.
Duloxetine
The metabolism of Ibrutinib can be decreased when combined with Duloxetine.
Econazole
The serum concentration of Ibrutinib can be increased when it is combined with Econazole.
Econazole Nitrate
The serum concentration of Ibrutinib can be increased when it is combined with Econazole.
Edetic Acid
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Edetic Acid.
Edoxaban
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Edoxaban.
Efavirenz
The serum concentration of Ibrutinib can be increased when it is combined with Efavirenz.
Elbasvir
The serum concentration of Ibrutinib can be increased when it is combined with Elbasvir.
Eliglustat
The metabolism of Ibrutinib can be decreased when combined with Eliglustat.
Enasidenib
The serum concentration of Ibrutinib can be increased when it is combined with Enasidenib.
Enoxaparin
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Enoxaparin.
Enoxaparin sodium
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Enoxaparin.
Enzalutamide
The serum concentration of Ibrutinib can be increased when it is combined with Enzalutamide.
Epinastine
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Epinastine.
Epinephrine
The serum concentration of Ibrutinib can be increased when it is combined with Epinephrine.
Epoprostenol
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Epoprostenol.
Eptifibatide
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Eptifibatide.
Ergonovine
The serum concentration of Ibrutinib can be increased when it is combined with Ergonovine.
Ergotamine
The serum concentration of Ibrutinib can be increased when it is combined with Ergotamine.
Erythromycin
The serum concentration of Ibrutinib can be increased when it is combined with Erythromycin.
Ethanol
The serum concentration of Ibrutinib can be increased when it is combined with Ethanol.
Ethylenediaminetetraacetate
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Edetic Acid.
Etoposide
The serum concentration of Ibrutinib can be increased when it is combined with Etoposide.
Etoricoxib
The serum concentration of Ibrutinib can be increased when it is combined with Etoricoxib.
Ezetimibe
The serum concentration of Ibrutinib can be increased when it is combined with Ezetimibe.
Felodipine
The serum concentration of Ibrutinib can be increased when it is combined with Felodipine.
Fentanyl
The serum concentration of Ibrutinib can be increased when it is combined with Fentanyl.
Ferulic Acid
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Ferulic acid.
Fingolimod
Ibrutinib may increase the immunosuppressive activities of Fingolimod.
Fluconazole
The serum concentration of Ibrutinib can be increased when it is combined with Fluconazole.
Fluindione
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Fluindione.
Fluoxetine
The serum concentration of Ibrutinib can be increased when it is combined with Fluoxetine.
Fluticasone propionate
The serum concentration of Ibrutinib can be increased when it is combined with Fluticasone propionate.
Fluvastatin
The serum concentration of Ibrutinib can be increased when it is combined with Fluvastatin.
Fluvoxamine
The serum concentration of Ibrutinib can be increased when it is combined with Fluvoxamine.
Fondaparinux sodium
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Fondaparinux sodium.
Fosamprenavir
The serum concentration of Ibrutinib can be increased when it is combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Ibrutinib can be increased when it is combined with Fosaprepitant.
Fosnetupitant
The serum concentration of Ibrutinib can be increased when it is combined with Fosnetupitant.
Fosphenytoin
The serum concentration of Ibrutinib can be decreased when it is combined with Fosphenytoin.
Fusidate
The serum concentration of Ibrutinib can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Ibrutinib can be increased when it is combined with Fusidic Acid.
Gemfibrozil
The serum concentration of Ibrutinib can be increased when it is combined with Gemfibrozil.
Gestodene
The serum concentration of Ibrutinib can be increased when it is combined with Gestodene.
Glecaprevir
The serum concentration of Ibrutinib can be increased when it is combined with Glecaprevir.
Glyburide
The serum concentration of Ibrutinib can be increased when it is combined with Glyburide.
Glycerol Phenylbutyrate
The serum concentration of Ibrutinib can be increased when it is combined with Glycerol Phenylbutyrate.
Haloperidol
The serum concentration of Ibrutinib can be increased when it is combined with Haloperidol.
Heparin
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Heparin.
Hepatitis A Vaccine, Inactivated
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Hepatitis A Vaccine.
Hepatitis B Surface Antigen Vaccine
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Hepatitis B Vaccine (Recombinant).
Histamine
The serum concentration of Ibrutinib can be increased when it is combined with Histamine.
Hydralazine
The serum concentration of Ibrutinib can be increased when it is combined with Hydralazine.
Hydrocortisone
The serum concentration of Ibrutinib can be increased when it is combined with Hydrocortisone.
Hydroxytyrosol
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Hydroxytyrosol.
Hypoxis hemerocallidea root extract
The serum concentration of Ibrutinib can be decreased when it is combined with St. John's Wort.
Icosapent Ethyl
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Icosapent ethyl.
Idelalisib
The serum concentration of Ibrutinib can be increased when it is combined with Idelalisib.
Ifenprodil
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Ifenprodil.
Ifosfamide
The serum concentration of Ibrutinib can be increased when it is combined with Ifosfamide.
Iloperidone
The serum concentration of Ibrutinib can be increased when it is combined with Iloperidone.
Iloprost
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Iloprost.
Imatinib
The serum concentration of Ibrutinib can be increased when it is combined with Imatinib.
Imipramine
The metabolism of Ibrutinib can be decreased when combined with Imipramine.
Indinavir
The serum concentration of Ibrutinib can be increased when it is combined with Indinavir.
INDINAVIR ANHYDROUS
The serum concentration of Ibrutinib can be increased when it is combined with Indinavir.
Indobufen
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Indobufen.
Irbesartan
The serum concentration of Ibrutinib can be increased when it is combined with Irbesartan.
Irinotecan
The serum concentration of Ibrutinib can be increased when it is combined with Irinotecan.
Isavuconazole
The serum concentration of Ibrutinib can be increased when it is combined with Isavuconazole.
Isavuconazonium
The serum concentration of Ibrutinib can be increased when it is combined with Isavuconazonium.
Isoniazid
The serum concentration of Ibrutinib can be increased when it is combined with Isoniazid.
Isradipine
The serum concentration of Ibrutinib can be increased when it is combined with Isradipine.
Itraconazole
The serum concentration of Ibrutinib can be increased when it is combined with Itraconazole.
Ivacaftor
The serum concentration of Ibrutinib can be increased when it is combined with Ivacaftor.
Josamycin
The serum concentration of Ibrutinib can be increased when it is combined with Josamycin.
Ketanserin
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Ketanserin.
Ketazolam
The serum concentration of Ibrutinib can be increased when it is combined with Ketazolam.
Ketoconazole
The serum concentration of Ibrutinib can be increased when it is combined with Ketoconazole.
Lansoprazole
The serum concentration of Ibrutinib can be increased when it is combined with Lansoprazole.
Lapatinib
The serum concentration of Ibrutinib can be increased when it is combined with Lapatinib.
Leflunomide
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Leflunomide.
Lepirudin
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Lepirudin.
Lercanidipine
The serum concentration of Ibrutinib can be increased when it is combined with Lercanidipine.
Letermovir
The serum concentration of Ibrutinib can be increased when it is combined with Letermovir.
Levalbuterol
The serum concentration of Ibrutinib can be increased when it is combined with Levosalbutamol.
Levofloxacin
The serum concentration of Ibrutinib can be increased when it is combined with Levofloxacin.
Levofloxacin Anhydrous
The serum concentration of Ibrutinib can be increased when it is combined with Levofloxacin.
Lidocaine
The serum concentration of Ibrutinib can be increased when it is combined with Lidocaine.
Linagliptin
The serum concentration of Ibrutinib can be increased when it is combined with Linagliptin.
Linseed Oil
Linseed oil may increase the antiplatelet activities of Ibrutinib.
Lipegfilgrastim
Ibrutinib may increase the myelosuppressive activities of Lipegfilgrastim.
Lomitapide
The serum concentration of Ibrutinib can be increased when it is combined with Lomitapide.
Lomustine
The serum concentration of Ibrutinib can be increased when it is combined with Lomustine.
Lopinavir
The serum concentration of Ibrutinib can be increased when it is combined with Lopinavir.
Loratadine
The serum concentration of Ibrutinib can be increased when it is combined with Loratadine.
Lorcaserin
The metabolism of Ibrutinib can be decreased when combined with Lorcaserin.
Losartan
The serum concentration of Ibrutinib can be increased when it is combined with Losartan.
Lovastatin
The serum concentration of Ibrutinib can be increased when it is combined with Lovastatin.
Luliconazole
The serum concentration of Ibrutinib can be increased when it is combined with Luliconazole.
Lumacaftor
The serum concentration of Ibrutinib can be decreased when it is combined with Lumacaftor.
Lumefantrine
The metabolism of Ibrutinib can be decreased when combined with Lumefantrine.
Lurasidone
The serum concentration of Ibrutinib can be increased when it is combined with Lurasidone.
Manidipine
The serum concentration of Ibrutinib can be increased when it is combined with Manidipine.
Mefloquine
The serum concentration of Ibrutinib can be increased when it is combined with Mefloquine.
Mequitazine
The serum concentration of Ibrutinib can be increased when it is combined with Mequitazine.
Methadone
The serum concentration of Ibrutinib can be increased when it is combined with Methadone.
Methazolamide
The serum concentration of Ibrutinib can be increased when it is combined with Methazolamide.
Methimazole
The serum concentration of Ibrutinib can be increased when it is combined with Methimazole.
Methotrimeprazine
The metabolism of Ibrutinib can be decreased when combined with Methotrimeprazine.
Methylergonovine
The serum concentration of Ibrutinib can be increased when it is combined with Methylergometrine.
Methylprednisolone
The serum concentration of Ibrutinib can be increased when it is combined with Methylprednisolone.
Metoprolol
The metabolism of Ibrutinib can be decreased when combined with Metoprolol.
Metronidazole
The serum concentration of Ibrutinib can be increased when it is combined with Metronidazole.
Metyrapone
The serum concentration of Ibrutinib can be increased when it is combined with Metyrapone.
Mibefradil
The serum concentration of Ibrutinib can be increased when it is combined with Mibefradil.
Miconazole
The serum concentration of Ibrutinib can be increased when it is combined with Miconazole.
Midazolam
The serum concentration of Ibrutinib can be increased when it is combined with Midazolam.
Midostaurin
The serum concentration of Ibrutinib can be increased when it is combined with Midostaurin.
Mifepristone
The serum concentration of Ibrutinib can be increased when it is combined with Mifepristone.
Milrinone
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Milrinone.
Mirabegron
The metabolism of Ibrutinib can be decreased when combined with Mirabegron.
Mirtazapine
The serum concentration of Ibrutinib can be increased when it is combined with Mirtazapine.
Mitotane
The serum concentration of Ibrutinib can be decreased when it is combined with Mitotane.
Mitoxantrone
The serum concentration of Ibrutinib can be increased when it is combined with Mitoxantrone.
Modafinil
The serum concentration of Ibrutinib can be increased when it is combined with Modafinil.
Nabilone
The serum concentration of Ibrutinib can be increased when it is combined with Nabilone.
Nadroparin
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Nadroparin.
Natalizumab
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Natalizumab.
Nefazodone
The serum concentration of Ibrutinib can be increased when it is combined with Nefazodone.
Nelfinavir
The serum concentration of Ibrutinib can be increased when it is combined with Nelfinavir.
Netupitant
The serum concentration of Ibrutinib can be increased when it is combined with Netupitant.
Nevirapine
The serum concentration of Ibrutinib can be increased when it is combined with Nevirapine.
Niacinamide
The serum concentration of Ibrutinib can be increased when it is combined with Nicotinamide.
Nicardipine
The serum concentration of Ibrutinib can be increased when it is combined with Nicardipine.
Nifedipine
The serum concentration of Ibrutinib can be increased when it is combined with Nifedipine.
Nilotinib
The serum concentration of Ibrutinib can be increased when it is combined with Nilotinib.
Nilvadipine
The serum concentration of Ibrutinib can be increased when it is combined with Nilvadipine.
Nimesulide
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Nimesulide.
Nisoldipine
The serum concentration of Ibrutinib can be increased when it is combined with Nisoldipine.
Nitrendipine
The serum concentration of Ibrutinib can be increased when it is combined with Nitrendipine.
Nitric Oxide
The serum concentration of Ibrutinib can be increased when it is combined with Nitric Oxide.
Norfloxacin
The serum concentration of Ibrutinib can be increased when it is combined with Norfloxacin.
Noscapine
The serum concentration of Ibrutinib can be increased when it is combined with Noscapine.
Ocrelizumab
Ocrelizumab may increase the immunosuppressive activities of Ibrutinib.
Olanzapine
The serum concentration of Ibrutinib can be increased when it is combined with Olanzapine.
Olaparib
The serum concentration of Ibrutinib can be increased when it is combined with Olaparib.
Omega-3 Fatty Acids
Omega-3 fatty acids may increase the antiplatelet activities of Ibrutinib.
Omeprazole
The serum concentration of Ibrutinib can be increased when it is combined with Omeprazole.
Osimertinib
The serum concentration of Ibrutinib can be increased when it is combined with Osimertinib.
Ouabain
Ouabain may decrease the cardiotoxic activities of Ibrutinib.
Ovine Digoxin Immune Fab
Digoxin Immune Fab (Ovine) may decrease the cardiotoxic activities of Ibrutinib.
Oxybutynin
The serum concentration of Ibrutinib can be increased when it is combined with Oxybutynin.
Oxymetholone
The serum concentration of Ibrutinib can be increased when it is combined with Oxymetholone.
Paclitaxel
The serum concentration of Ibrutinib can be increased when it is combined with Paclitaxel.
Palbociclib
The serum concentration of Ibrutinib can be increased when it is combined with Palbociclib.
Panobinostat
The serum concentration of Ibrutinib can be increased when it is combined with Panobinostat.
Paramethasone
The serum concentration of Ibrutinib can be increased when it is combined with Paramethasone.
Paroxetine
The metabolism of Ibrutinib can be decreased when combined with Paroxetine.
Pazopanib
The serum concentration of Ibrutinib can be increased when it is combined with Pazopanib.
Peginterferon Alfa-2b
The serum concentration of Ibrutinib can be decreased when it is combined with Peginterferon alfa-2b.
Pentaerythritol Tetranitrate
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Pentaerythritol Tetranitrate.
Pentobarbital
The serum concentration of Ibrutinib can be decreased when it is combined with Pentobarbital.
Pentosan Polysulfate
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Pentosan Polysulfate.
Pentoxifylline
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Pentoxifylline.
Peppermint oil
The serum concentration of Ibrutinib can be increased when it is combined with Peppermint oil.
Pergolide
The serum concentration of Ibrutinib can be increased when it is combined with Pergolide.
Phenelzine
The serum concentration of Ibrutinib can be increased when it is combined with Phenelzine.
Phenindione
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Phenindione.
Phenobarbital
The serum concentration of Ibrutinib can be decreased when it is combined with Phenobarbital.
Phenprocoumon
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Phenprocoumon.
Phenytoin
The serum concentration of Ibrutinib can be decreased when it is combined with Phenytoin.
Phospholipids
Omega-3 fatty acids may increase the antiplatelet activities of Ibrutinib.
Pibrentasvir
The serum concentration of Ibrutinib can be increased when it is combined with Pibrentasvir.
Pilocarpine
The serum concentration of Ibrutinib can be increased when it is combined with Pilocarpine.
Pimecrolimus
The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Ibrutinib.
Pimozide
The serum concentration of Ibrutinib can be increased when it is combined with Pimozide.
Posaconazole
The serum concentration of Ibrutinib can be increased when it is combined with Posaconazole.
Potassium Citrate
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Potassium Citrate.
Prasterone
The serum concentration of Ibrutinib can be increased when it is combined with Prasterone.
Prasugrel
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Prasugrel.
Pravastatin
The serum concentration of Ibrutinib can be increased when it is combined with Pravastatin.
Prednisolone
The serum concentration of Ibrutinib can be increased when it is combined with Prednisolone.
Prednisone
The serum concentration of Ibrutinib can be increased when it is combined with Prednisone.
Primaquine
The serum concentration of Ibrutinib can be increased when it is combined with Primaquine.
Primidone
The serum concentration of Ibrutinib can be decreased when it is combined with Primidone.
Progesterone
The serum concentration of Ibrutinib can be increased when it is combined with Progesterone.
Promazine
The metabolism of Ibrutinib can be decreased when combined with Promazine.
Propofol
The serum concentration of Ibrutinib can be increased when it is combined with Propofol.
Propoxyphene
The serum concentration of Ibrutinib can be increased when it is combined with Dextropropoxyphene.
Proscillaridin
Proscillaridin may decrease the cardiotoxic activities of Ibrutinib.
protein C, human
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Protein C.
protein S, human
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Protein S human.
Protocatechualdehyde
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Protocatechualdehyde.
Quinidine
The serum concentration of Ibrutinib can be increased when it is combined with Quinidine.
Quinine
The serum concentration of Ibrutinib can be increased when it is combined with Quinine.
Quinupristin
The serum concentration of Ibrutinib can be increased when it is combined with Quinupristin.
Rabeprazole
The serum concentration of Ibrutinib can be increased when it is combined with Rabeprazole.
Rabies Immune Globulin, Human
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Human rabies virus immune globulin.
Rabies Virus Vaccine Flury-Lep Strain
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Rabies virus inactivated antigen, A.
Raloxifene
The serum concentration of Ibrutinib can be increased when it is combined with Raloxifene.
Ranitidine
The serum concentration of Ibrutinib can be increased when it is combined with Ranitidine.
Ranolazine
The serum concentration of Ibrutinib can be increased when it is combined with Ranolazine.
Regorafenib
The serum concentration of Ibrutinib can be increased when it is combined with Regorafenib.
Repaglinide
The serum concentration of Ibrutinib can be increased when it is combined with Repaglinide.
Resveratrol
The serum concentration of Ibrutinib can be increased when it is combined with Resveratrol.
Reviparin
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Reviparin.
Reviparin sodium
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Reviparin.
Ribociclib
The serum concentration of Ibrutinib can be increased when it is combined with Ribociclib.
Rifabutin
The serum concentration of Ibrutinib can be decreased when it is combined with Rifabutin.
Rifampin
The serum concentration of Ibrutinib can be decreased when it is combined with Rifampicin.
Rifapentine
The serum concentration of Ibrutinib can be decreased when it is combined with Rifapentine.
Rilpivirine
The serum concentration of Ibrutinib can be increased when it is combined with Rilpivirine.
Risperidone
The serum concentration of Ibrutinib can be increased when it is combined with Risperidone.
Ritonavir
The serum concentration of Ibrutinib can be increased when it is combined with Ritonavir.
Rivaroxaban
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Rivaroxaban.
Rivastigmine
The serum concentration of Ibrutinib can be increased when it is combined with Rivastigmine.
Roflumilast
Roflumilast may increase the immunosuppressive activities of Ibrutinib.
Rolapitant
The metabolism of Ibrutinib can be decreased when combined with Rolapitant.
Rolitetracycline
The serum concentration of Ibrutinib can be increased when it is combined with Rolitetracycline.
Ropinirole
The metabolism of Ibrutinib can be decreased when combined with Ropinirole.
Rosuvastatin
The serum concentration of Ibrutinib can be increased when it is combined with Rosuvastatin.
ROTAVIRUS VACCINE, LIVE
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Rotavirus Vaccine.
Roxithromycin
The serum concentration of Ibrutinib can be increased when it is combined with Roxithromycin.
Rubella Virus Vaccine Live (wistar Ra 27-3 Strain)
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Rubella virus vaccine.
Rucaparib
The serum concentration of Ibrutinib can be increased when it is combined with Rucaparib.
Rutin
The serum concentration of Ibrutinib can be increased when it is combined with Rutin.
Salmonella enterica subsp. enterica serovar typhi
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Salmonella typhi ty21a live antigen.
Saquinavir
The serum concentration of Ibrutinib can be increased when it is combined with Saquinavir.
Saquinavir Mesylate
The serum concentration of Ibrutinib can be increased when it is combined with Saquinavir.
Sarilumab
The serum concentration of Ibrutinib can be increased when it is combined with Sarilumab.
Sertraline
The serum concentration of Ibrutinib can be increased when it is combined with Sertraline.
Sevoflurane
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Sevoflurane.
Sildenafil
The serum concentration of Ibrutinib can be increased when it is combined with Sildenafil.
Siltuximab
The serum concentration of Ibrutinib can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Ibrutinib can be increased when it is combined with Simeprevir.
Simvastatin
The serum concentration of Ibrutinib can be increased when it is combined with Simvastatin.
sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Ibrutinib.
Sirolimus
The serum concentration of Ibrutinib can be increased when it is combined with Sirolimus.
Sodium Citrate
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Sodium Citrate.
Sorafenib
The serum concentration of Ibrutinib can be increased when it is combined with Sorafenib.
ST. JOHN'S WORT EXTRACT
The serum concentration of Ibrutinib can be decreased when it is combined with St. John's Wort.
Sulfamethoxazole
The serum concentration of Ibrutinib can be increased when it is combined with Sulfamethoxazole.
Sulfanilamide
The serum concentration of Ibrutinib can be increased when it is combined with Sulfanilamide.
Sulfinpyrazone
The serum concentration of Ibrutinib can be increased when it is combined with Sulfinpyrazone.
Sulfisoxazole
The serum concentration of Ibrutinib can be increased when it is combined with Sulfisoxazole.
Tacrolimus
The serum concentration of Ibrutinib can be increased when it is combined with Tacrolimus.
Tadalafil
The serum concentration of Ibrutinib can be increased when it is combined with Tadalafil.
Tamoxifen
The serum concentration of Ibrutinib can be increased when it is combined with Tamoxifen.
Telaprevir
The serum concentration of Ibrutinib can be increased when it is combined with Telaprevir.
Telithromycin
The serum concentration of Ibrutinib can be increased when it is combined with Telithromycin.
Temsirolimus
The serum concentration of Ibrutinib can be increased when it is combined with Temsirolimus.
Teniposide
The serum concentration of Ibrutinib can be increased when it is combined with Teniposide.
Terbinafine
The metabolism of Ibrutinib can be decreased when combined with Terbinafine.
Terfenadine
The serum concentration of Ibrutinib can be increased when it is combined with Terfenadine.
Testosterone
The serum concentration of Ibrutinib can be increased when it is combined with Testosterone.
Testosterone Cypionate
The serum concentration of Ibrutinib can be increased when it is combined with Testosterone cypionate.
Testosterone Enanthate
The serum concentration of Ibrutinib can be increased when it is combined with Testosterone enanthate.
Testosterone Undecanoate
The serum concentration of Ibrutinib can be increased when it is combined with Testosterone undecanoate.
Tetanus Toxoid Vaccine, Inactivated
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Clostridium tetani toxoid antigen (formaldehyde inactivated).
Tetracycline
The serum concentration of Ibrutinib can be increased when it is combined with Tetracycline.
Thiopental
The serum concentration of Ibrutinib can be increased when it is combined with Thiopental.
Thiopental Sodium
The serum concentration of Ibrutinib can be increased when it is combined with Thiopental.
Thioridazine
The metabolism of Ibrutinib can be decreased when combined with Thioridazine.
Ticagrelor
The serum concentration of Ibrutinib can be increased when it is combined with Ticagrelor.
Ticlopidine
The serum concentration of Ibrutinib can be increased when it is combined with Ticlopidine.
Tioconazole
The serum concentration of Ibrutinib can be increased when it is combined with Tioconazole.
Tipranavir
The serum concentration of Ibrutinib can be increased when it is combined with Tipranavir.
Tirofiban
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Tirofiban.
Tocilizumab
The serum concentration of Ibrutinib can be decreased when it is combined with Tocilizumab.
Tofacitinib
Ibrutinib may increase the immunosuppressive activities of Tofacitinib.
Tofisopam
The serum concentration of Ibrutinib can be increased when it is combined with Tofisopam.
Topotecan
The serum concentration of Ibrutinib can be increased when it is combined with Topotecan.
Tramadol
The serum concentration of Ibrutinib can be increased when it is combined with Tramadol.
Tranilast
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Tranilast.
Tranylcypromine
The serum concentration of Ibrutinib can be increased when it is combined with Tranylcypromine.
Trapidil
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Trapidil.
Trastuzumab
Trastuzumab may increase the cardiotoxic activities of Ibrutinib.
Triflusal
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Triflusal.
Trisodium Citrate Anhydrous
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Sodium Citrate.
Troglitazone
The serum concentration of Ibrutinib can be increased when it is combined with Troglitazone.
Troleandomycin
The serum concentration of Ibrutinib can be increased when it is combined with Troleandomycin.
Troxerutin
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Troxerutin.
Typhoid Vaccine Live Ty21a
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Salmonella typhi ty21a live antigen.
Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Salmonella typhi ty2 vi polysaccharide antigen.
Valproate
The serum concentration of Ibrutinib can be increased when it is combined with Valproic Acid.
Valproic Acid
The serum concentration of Ibrutinib can be increased when it is combined with Valproic Acid.
Varicella Virus Vaccine Live (Oka-Merck) strain
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Varicella Zoster Vaccine (Live/Attenuated).
Vemurafenib
The serum concentration of Ibrutinib can be decreased when it is combined with Vemurafenib.
Venlafaxine
The serum concentration of Ibrutinib can be increased when it is combined with Venlafaxine.
Verapamil
The serum concentration of Ibrutinib can be increased when it is combined with Verapamil.
Vinblastine
The serum concentration of Ibrutinib can be increased when it is combined with Vinblastine.
Vincristine
The serum concentration of Ibrutinib can be increased when it is combined with Vincristine.
Vinorelbine
The serum concentration of Ibrutinib can be increased when it is combined with Vinorelbine.
Vitamin E
Vitamin E may increase the antiplatelet activities of Ibrutinib.
Vorapaxar
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Vorapaxar.
Voriconazole
The serum concentration of Ibrutinib can be increased when it is combined with Voriconazole.
Warfarin
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Warfarin.
Yellow Fever Vaccine
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Yellow Fever Vaccine.
Yellow-Fever Virus Vaccine, 17D-204 strain
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Yellow Fever Vaccine.
Zafirlukast
The serum concentration of Ibrutinib can be increased when it is combined with Zafirlukast.
Ziprasidone
The serum concentration of Ibrutinib can be increased when it is combined with Ziprasidone.
